Title : Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan.

Pub. Date : 2022 Apr 15

PMID : 35428708






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVE: The calcineurin inhibitor tacrolimus has been approved in Japan for the treatment of interstitial pneumonia in patients with polymyositis (PM) and dermatomyositis (DM). Tacrolimus calcineurin binding protein 1 Homo sapiens